Merit Medical Systems Inc當前公司基本面數據相對非常健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名12/206位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價103.00。中期看,股價處於平穩狀態。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。
Merit Medical Systems Inc評分
相關信息
行業排名
12 / 206
全市場排名
69 / 4562
所屬行業
醫療設備與耗材
壓力支撐
由於公司未披露,未能獲取相關數據
多維評測
本期評分
上期評分
分析師目標
基於
11
分析師
買入
評級
103.000
目標均價
+23.93%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議
Merit Medical Systems Inc亮點
亮點風險
Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of medical devices used in interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories is used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in clinical areas, such as radiology, electrophysiology and more. It also manufactures hemostatic devices under the brand names StatSeal and WoundSeal.
Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of medical devices used in interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories is used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in clinical areas, such as radiology, electrophysiology and more. It also manufactures hemostatic devices under the brand names StatSeal and WoundSeal.
公司代碼MMSI
公司Merit Medical Systems Inc
CEOAronson (Martha Goldberg)
網址https://www.merit.com/
常見問題
Merit Medical Systems Inc(MMSI)的當前股價是多少?
Merit Medical Systems Inc(MMSI)的當前股價是 87.390。
Merit Medical Systems Inc 的股票代碼是什麼?
Merit Medical Systems Inc的股票代碼是MMSI。
Merit Medical Systems Inc股票的52週最高點是多少?
Merit Medical Systems Inc股票的52週最高點是111.450。
Merit Medical Systems Inc股票的52週最低點是多少?
Merit Medical Systems Inc股票的52週最低點是78.116。
Merit Medical Systems Inc的市值是多少?
Merit Medical Systems Inc的市值是5.18B。
Merit Medical Systems Inc的淨利潤是多少?
Merit Medical Systems Inc的淨利潤為120.36M。
現在Merit Medical Systems Inc(MMSI)的股票是買入、持有還是賣出?
根據分析師評級,Merit Medical Systems Inc(MMSI)的總體評級為買入,目標價格為103.000。
Merit Medical Systems Inc(MMSI)股票的每股收益(EPS TTM)是多少
Merit Medical Systems Inc(MMSI)股票的每股收益(EPS TTM)是2.008。